Trial intelligence / Profile preview

COSEX: Combined Oral Contraceptives and Female Sexuality

NCT02613039Phase 4Completed

Sponsor
Università degli Studi di Firenze
Start
Oct 2015
Primary completion
Feb 2018
Countries
1
01

Overview

Phase 4, open-label trial in contraception, sponsored by Università degli Studi di Firenze. Primary endpoints: Female Sexual Function Index at 12 months, Female Sexual Distress Scale Revised at 12 months and 1 more. Started Oct 2015; status: completed.

02

Conditions

contraception

Beyond the preview

Go deeper on NCT02613039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02613039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call